Inflammatory markers in major depression and melancholia

Journal of Affective Disorders

Volumn 63, Issue 1-3, 2001, Pages 93-102

  Rothermundt, Matthias ^a   Arolt, Volker ^a   Peters, Marion ^a   Gutbrodt, Heike ^b   Fenker, Jan ^b   Kersting, Anette ^a   Kirchner, Holger ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Acute phase proteins; Cytokines; Immunology; Major depression; Melancholia; Monocytes

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; HAPTOGLOBIN; INTERLEUKIN 1BETA; MARKER;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD LEVEL; CELL COUNT; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMMUNITY; INFLAMMATION; LASER NEPHELOMETRY; MALE; MELANCHOLIA; MONOCYTE; MORPHOLOGY; PRIORITY JOURNAL;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; BLOOD CELL COUNT; DEPRESSIVE DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; MALE; MIDDLE AGED;

EID: 0035089606     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00157-9     Document Type: Article

References (40)

1. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders
2. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features
3. Methodische Untersuchungen zur Hamilton-Depression-Skala
4. Acute phase proteins in major depression
5. Opioid peptides and immunodysfunction in patients with major depression and anxiety disorders
6. Immune cells and the hypothalamic-pituitary axis in major depression
7. A rating scale for depression
8. Low natural killer cytotoxicity in major depression
9. Elevated levels of acute phase proteins in major depression
10. A whole-blood technique for testing production of human interferon by leukocytes
11. Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders
12. Stress and the immune system in the etiology of anxiety and depression
13. Immune cell parameters in severely depressed patients: Negative findings
14. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin- 1β and soluble interleukin-2 receptor production
15. Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness
16. Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression
17. Higher alpha1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness
18. Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression
19. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression
20. Interleukin-1beta: A putative mediator of HPA axis hyperactivity in major depression?
21. Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobinemia during major depression
22. Natural killer cell activity in major depression: Relation to circulating natural killer cells. Cellular indices of the immune response, and depressive phenomenology
23. Absolute number and percentage of circulating natural killer. Non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression
24. Haptoglobin phenotypes and gene frequencies in unipolar major depression
25. Evidence for an immune response in major depression: A review and hypothesis
26. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
27. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: Relationships with immune-inflammatory markers
28. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs
29. Neutrophil and monocyte phagocytosis in depressed patients
30. Is depression associated with immune activation?
31. Variations of lymphocyte subsets associated with stress in depressive populations
32. The composite international diagnostic interview
33. Cytokine production and serum proteins in depression
34. + natural killer cells and related cytokines in major depression
35. Indicators of immune activation in major depression
36. Concentration and microheterogeneity glycophorms of α-1-acid glycoprotein in major depressive disorder
37. Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression
38. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls
39. Cytokine production in major depressed patients before and after clomipramine treatment